|
🦁
|
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
106 auth.
Vincent C. Marconi,
A. Ramanan,
S. de Bono,
Cynthia E. Kartman,
V. Krishnan,
R. Liao,
M. L. B. Piruzeli,
Jason D. Goldman,
Jorge Alatorre-Alexander,
Rita de Cassia Pellegrini,
Vicente Estrada,
Mousumi Som,
A. Cardoso,
Sujatro Chakladar,
Brenda J. Crowe,
...
P. Reis,
X. Zhang,
D. Adams,
E. W. Ely,
M. Ahn,
M. Akasbi,
Jorge Alatorre-Alexander,
J. Altclas,
F. Ariel,
H. Ariza,
C. Atkar,
A. Bertetti,
M. Bhattacharya,
M. L. Briones,
A. Budhraja,
A. Burza,
Adrian Camacho Ortiz,
R. Caricchio,
M. Casas,
Valeria Cevoli Recio,
W. Choi,
Emilia Cohen,
Angel Comulada-Rivera,
Paul Cook,
Dora Patricia Cornejo Juarez,
Carnevali Daniel,
Luiz Fernando Degrecci Relvas,
Jose Guillermo Dominguez Cherit,
T. Ellerin,
D. Enikeev,
Suzana Erico Tanni Minamoto,
Vicente Estrada,
E. Fiss,
M. Furuichi,
Kleber Giovanni Luz,
Jason D. Goldman,
O. González,
I. Gordeev,
T. Gruenewald,
Victor Augusto Hamamoto Sato,
Eun Young Heo,
J. Heo,
M. Hermida,
Yuji Hirai,
D. Hutchinson,
Claudio Iastrebner,
O. Ioachimescu,
Manish Jain,
Maria Patelli Juliani Souza Lima,
Akram Khan,
A. Kremer,
T. Lawrie,
Mark Macelwee,
F. Madhani-Lovely,
V. Malhotra,
M. F. Martínez Resendez,
James McKinnell,
P. Milligan,
C. Minelli,
Miguel Ángel Morán Rodríguez,
M. L. Parody,
P. Paulin,
R. Pellegrini,
Priscilla Pemu,
Ana Carolina Procopio Carvalho,
M. Puoti,
J. Purow,
M. Ramesh,
Álvaro Réa Neto,
Philip G. Robinson,
Cristhieni Rodrigues,
Gustavo Rojas Velasco,
J. Saraiva,
M. Scheinberg,
S. Schreiber,
D. Scublinsky,
A. Sevciovic Grumach,
Imad Shawa,
J. S. Simón Campos,
N. Sofat,
Mousumi Som,
C. Spinner,
E. Sprinz,
R. Stienecker,
J. Suárez,
N. Tachikawa,
H. Tahir,
B. Tiffany,
A. Vishnevsky,
Adilson Westheimer Cavalcante,
K. Zirpe
|
8 |
2021 |
8
🦁
|
|
🐜
|
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
27 auth.
E. W. Ely,
A. Ramanan,
Cynthia E. Kartman,
S. de Bono,
R. Liao,
M. L. B. Piruzeli,
Jason D. Goldman,
J. Saraiva,
Sujatro Chakladar,
Vincent C. Marconi,
Jorge Alatorre-Alexander,
J. Altclas,
M. Casas,
Valeria CevoliRecio,
T. Ellerin,
...
Kleber Giovanni Luz,
Jason D. Goldman,
Maria Patelli Juliani Souza Lima,
Akram Khan,
P. Paulin,
Ana Carolina Procopio Carvalho,
Gustavo Rojas Velasco,
J. Saraiva,
Imad Shawa,
J. S. Simón Campos,
B. Tiffany,
Adilson Westheimer Cavalcante
|
6 |
2022 |
6
🐜
|
|
🐜
|
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
7 auth.
N. Chandiwana,
M. Siedner,
Vincent C. Marconi,
A. Hill,
Mohammed K. Ali,
R. Batterham,
...
W. Venter
|
4 |
2023 |
4
🐜
|
|
🐢
|
Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial
Tsegahun Manyazewal,
Y. Woldeamanuel,
D. Holland,
A. Fekadu,
Vincent C. Marconi
|
4 |
2022 |
4
🐢
|
|
🐜
|
Mapping digital health ecosystems in Africa in the context of endemic infectious and non-communicable diseases
14 auth.
Tsegahun Manyazewal,
Mohammed K. Ali,
T. Kebede,
M. Magee,
T. Getinet,
Shivani A. Patel,
D. Hailemariam,
C. Escoffery,
Y. Woldeamanuel,
Nardos Makonnen,
...
Samrawit Solomon,
W. Amogne,
Vincent C. Marconi,
A. Fekadu
|
4 |
2023 |
4
🐜
|
|
🐢
|
Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial
10 auth.
Tsegahun Manyazewal,
Y. Woldeamanuel,
T. Getinet,
Alison Hoover,
K. Bobosha,
Oumer Fuad,
...
B. Getahun,
A. Fekadu,
D. Holland,
Vincent C. Marconi
|
3 |
2023 |
3
🐢
|
|
🐢
|
Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis
Tsegahun Manyazewal,
Y. Woldeamanuel,
A. Fekadu,
D. Holland,
Vincent C. Marconi
|
3 |
2022 |
3
🐢
|
|
🐜
|
U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment
9 auth.
S. Graham,
D. Barthold,
Brett Hauber,
Aaron T. Brah,
E. Saldarriaga,
A. Collier,
...
Rodney J Y Ho,
Vincent C. Marconi,
J. Simoni
|
3 |
2023 |
3
🐜
|
|
🐜
|
Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study.
18 auth.
Anthony N. Muiru,
E. Madden,
R. Scherzer,
M. Horberg,
M. Silverberg,
M. Klein,
Á. Mayor,
M. Gill,
S. Napravnik,
H. Crane,
...
Vincent C. Marconi,
J. Koethe,
A. Abraham,
K. Althoff,
G. Lucas,
R. Moore,
M. Shlipak,
M. Estrella
|
3 |
2022 |
3
🐜
|
